文献速递心血管MR

疑似或已知冠心病患者双嘧达莫负荷心脏磁共振诱发性室壁运动异常的长期增量预后价值缺失

Absence of long-term incremental prognostic value of inducible wall motion abnormalities on dipyridamole stress CMR in patients with suspected or known coronary artery disease.
PubMed 文献 · Eur Radiol · 2024-11-28

该单中心回顾性研究纳入278例接受双嘧达莫负荷心脏磁共振的疑似或已知冠心病患者,评估灌注和室壁运动两个缺血级联关键时相的长期(约5年)预后价值。结果显示阳性负荷心脏磁共振预测心血管事件风险升高,但诱发性室壁运动异常在可逆性灌注缺损之外未显示额外预后价值。

要点

  • 阳性双嘧达莫负荷心脏磁共振预测长期心血管事件风险升高
  • 诱发性室壁运动异常较单纯可逆性灌注缺损无额外预后价值
  • 可逆性灌注缺损患者可能适合更积极管理以降低长期风险

核心结论

  • 阳性双嘧达莫负荷心脏磁共振预测更高的长期心血管事件风险,但诱发性室壁运动异常较可逆性灌注缺损未显示任何额外预后价值。

研究设计与样本

  • 单中心回顾性研究,连续纳入322例接受双嘧达莫负荷心脏磁共振的患者,排除44例早期血运重建后最终分析278例(女性73例,年龄62.42 ± 10.50岁)。

关键影像表现/征象

  • 78例(28.1%)患者负荷心脏磁共振阳性,其中50例至少一个心肌节段存在可逆性负荷灌注缺损,28例存在可逆性负荷灌注缺损并伴负荷室壁运动较静息恶化。
  • 分析内容包括静息及双嘧达莫负荷后室壁运动、负荷及静息灌注和晚期钆增强。

诊断标准与关键数值

  • 阳性负荷心脏磁共振定义为存在可逆性负荷灌注缺损,或可逆性负荷灌注缺损伴负荷室壁运动恶化。
  • 多变量Cox回归中,糖尿病HR=5.64(p<0.0001),可逆性灌注缺损vs正常负荷心脏磁共振HR=6.43(p<0.0001),可逆性灌注+运动缺损vs正常HR=4.57(p=0.004),LVEF HR=0.96(p=0.010)。

临床应用与阅片要点

  • 作者指出,独立于室壁运动异常的存在,可逆性灌注缺损患者可能适合更积极的管理以降低长期心血管事件风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This single-center retrospective study evaluated the long-term (~5 years) prognostic value of dipyridamole stress cardiac magnetic resonance (CMR) in patients with known or suspected coronary artery disease (CAD), assessing the impact of both key phases of the ischemic cascade (perfusion and wall motion).

MATERIAL AND METHODS: We considered 322 consecutive patients who underwent dipyridamole stress CMR. Abnormal wall motion at rest and after dipyridamole, perfusion at stress and at rest, and late gadolinium enhancement (LGE) were analyzed. End-points were non-fatal myocardial infarction, unplanned late revascularization (60 days after CMR), and cardiac death.

RESULTS: Forty-four patients were excluded because they underwent early revascularization (within 60 days after stress CMR), leading to a final population of 278 patients (73 females, 62.42 ± 10.50 years). A positive stress CMR was found in 78 (28.1%) patients; 50 patients had a reversible stress perfusion defect in at least one myocardial segment and 28 had a reversible stress perfusion defect plus worsening of stress wall motion in comparison with the rest. During a mean follow-up time of 59.34 ± 31.72 months, 37 (13.3%) cardiac events were recorded: 10 cardiac deaths, one non-fatal myocardial infarction, and 26 late revascularization after unstable angina or myocardial infarction. According to the Cox regression analysis, age, diabetes mellitus, previous revascularization, left ventricular ejection fraction (LVEF), reversible perfusion and perfusion + motion defect, and LGE were significant univariate prognosticators. The presence of associated wall motion abnormality (WMA) did not provide additional prognostic stratification in comparison to the only perfusion defect. In the multivariate Cox regression, the independent predictive factors were diabetes (hazard-ratio-HR = 5.64, p < 0.0001), reversible perfusion defect and reversible perfusion + motion defect vs normal stress CMR (HR = 6.43, p < 0.0001, and HR = 4.57, p = 0.004; respectively), and LVEF (HR = 0.96, p = 0.010).

CONCLUSION: A positive dipyridamole stress CMR predicted a higher long-term risk of cardiovascular events, but the presence of inducible WMA did not show any additional prognostic value over the reversible perfusion defect.

KEY POINTS: Question The long-term incremental prognostic value of inducible wall motion abnormalities by stress cardiac MR in patients with known or suspected CAD requires investigation. Findings The presence of inducible wall motion abnormalities did not offer additional prognostic value in comparison to the only reversible perfusion defect. Clinical relevance Independent from the presence of wall motion abnormalities, more aggressive management may be appropriate in patients with reversible perfusion defects to reduce the long-term risk of cardiovascular events.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Meloni A, Nugara C, De Luca A, et al. Absence of long-term incremental prognostic value of inducible wall motion abnormalities on dipyridamole stress CMR in patients with suspected or known coronary artery disease. Eur Radiol. 2024. PMID: 39607451. doi:10.1007/s00330-024-11229-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。